LONDON, April 24, 2017 /PRNewswire/ -- This expansion is attributed to the increasing cases of trauma and rising number ofhospital and trauma care centers facilitating emergency treatments. This creates a need to procure blood to suffice the demand, thus, boosting the market for immunohematology tests and products. A deeper analysis on the report at https://www.reportbuyer.com/product/4523071/In
· In December 2013, Sysmex Corporation received the German Design Award for its XN-2000 hematology reagent. Almost 1,900 products were nominated for the award.
· In 2015, North America dominated the market with a revenue share of more than 40%. In the U.S., there is a patient requiring transfusion every 2 seconds. The daily consumption of blood is approximately 36,000 units per day. This indicates the huge opportunity of growth in this region.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-immunohematology-market-forecast-to-value-usd-23-billion-by-2024-300444490.html
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All